Plain-English translation of NCT07356089 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is tracking how twiist, an automated insulin delivery pump, works in real life for people with type 1 diabetes. Researchers want to understand how safe and effective the medication delivery system is when people use it at home, at school, and in their daily routines. This helps make sure the treatment continues to be safe and helpful for everyone who uses it.
Even after a medical device is approved and available to patients, companies are required to keep watching how it performs in the real world. This study exists to spot any unexpected safety issues and learn how well this treatment actually works when people use it day-to-day, outside of a controlled research setting.
You likely qualify if…
You likely don't qualify if…
You would use your insulin pump as directed and allow the study team to access the pump's data and any information you've shared with customer support. You'll complete brief surveys at the start of the study and then once per month for 12 months. The study team may contact you if they need to clarify any health events you report, and they may ask to review hospital records if you have any serious health issues during the year.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States
Sponsor
Deka Research and Development
Collaborators
Jaeb Center for Health Research
Enrollment target
~1,875 participants
Started
December 2025
Primary completion
May 2027
Age range
6 Years and older
Last updated on clinicaltrials.gov in January 2026.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.